Skip to main content

Clinical Trials Using Azacitidine

Review the clinical trials studying azacitidine on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 76-89 of 89

A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS
Status: Active
Location: See ClinicalTrials.gov
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Status: Active
Location: See ClinicalTrials.gov
Venetoclax to Augment Epigenetic Modification and Chemotherapy
Status: Active
Location: See ClinicalTrials.gov
Ascorbate with Azacitidine and Venetoclax for the Treatment of Newly Diagnosed Acute Myeloid Leukemia
Status: Approved
Location: University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa
Azacitidine and Pembrolizumab in Treating Patients with Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas
Nivolumab and/or Ipilimumab with or without Azacitidine in Treating Patients with Myelodysplastic Syndrome
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas
Venetoclax in Combination with Conventional Chemotherapy for the Treatment of Pediatric Patients with Acute Myeloid Leukemia
Status: Temporarily Closed to Accrual
Location: 9 locations
A Study Evaluating the Safety and Efficacy of IBI188 in Combination With AZA in Subjects With Newly Diagnosed MDS
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas
Venetoclax in Combination with Azacitidine followed by Donor Lymphocyte Infusion for the Treatment of Patients with Very High-Risk Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant
Status: Temporarily Closed to Accrual
Location: University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida
Venetoclax and Azacitidine or Chemotherapy for the Treatment of Hematologic Malignancies in Pediatric and Young Adult Patients
Status: Temporarily Closed to Accrual
Location: 6 locations
Venetoclax, Busulfan, Fludarabine, Azacitidine, Decitabine, and Cedazuridine in Treating Patients with High Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, and Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndromes Undergoing Donor Stem Cell Transplantation
Status: Temporarily Closed to Accrual
Location: 2 locations
Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Patients with Blood Cancers
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
MYELOMATCH: A Screening Study to Assign People with Myeloid Cancer to a Treatment Study or Standard of Care Treatment within myeloMATCH (MyeloMATCH Screening Trial)
Status: Active
Location: 316 locations
Microdevice for In Situ Candidate Drug Screening in Skin Lesions of T-Cell Lymphoma
Status: Active
Location: 2 locations